The death of an important drug like aducanumab will have both a short and a long term effect on Biogen as a company and especially on R&D.
How Will The Failure Of Biogen’s Alzheimer’s Drug, Aducanumab, Impact R&D?
The death of an important drug like aducanumab will have both a short and a long term effect on Biogen as a company and especially on R&D.